Grail bets big on flagship cancer test after spin-off from Illumina
Go back to Grail bets big on flagship cancer test after spin-off from Illumina| (NASDAQ: GRAL) | Delayed: 76.23 -1.33 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $77.56 | 52 Week High | $ | |||
| Open | $77.61 | 52 Week Low | $ | |||
| Day High | $79.19 | P/E | N/A | |||
| Day Low | $76.14 | EPS | $ | |||
| Volume | 360,986 | |||||
| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 206.45 +5.18 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $201.27 | 52 Week High | $196.47 | |||
| Open | $201.81 | 52 Week Low | $127.10 | |||
| Day High | $208.39 | P/E | 229.39 | |||
| Day Low | $200.01 | EPS | $0.90 | |||
| Volume | 2,412,386 | |||||
